Related Experiment Videos
Genetic aspects of microangiopathy-related cerebral damage
H Schmidt1, F Fazekas, G M Kostner
1Institute of Medical Biochemistry, Karl-Franzens University, Graz, Austria.
Abstract:
Microangiopathy related cerebral damage (MARCD) includes early confluent and confluent white matter hyperintensities (WMH) and lacunar lesions. It is expected to be the result of interactions between multiple genetic and environmental factors. The estimated proportion of genetic factors contributing to the interindividual variation seen in WMH volume is 73%. This estimate points to a significant genetic component in WMH development. In the setting of the Austrian Stroke Prevention Study we search for genes being associated with the presence, severity and progression of MARCD using the candidate gene approach. Defining susceptibility genes may allow to better identify individuals at high risk for MARCD and to target preventive measures.
Insights
Genetic factors significantly influence white matter hyperintensities (WMH) in microangiopathy-related cerebral damage (MARCD). Research aims to identify susceptibility genes for MARCD to improve early detection and prevention strategies.
Area of Science:
- Neurology
- Genetics
- Cerebrovascular disease
Background:
- Microangiopathy-related cerebral damage (MARCD) encompasses white matter hyperintensities (WMH) and lacunar lesions.
- MARCD results from complex interactions between genetic and environmental factors.
- Genetic factors account for an estimated 73% of interindividual variation in WMH volume, highlighting a substantial genetic influence.
Purpose of the Study:
- To identify genes associated with the presence, severity, and progression of MARCD.
- To utilize a candidate gene approach within the Austrian Stroke Prevention Study cohort.
- To define susceptibility genes for improved risk identification and targeted preventive measures.
Main Methods:
- Candidate gene association study.
- Analysis of genetic factors contributing to WMH volume and MARCD.
- Utilizing data from the Austrian Stroke Prevention Study.
Main Results:
- A significant genetic component (73%) influences WMH volume.
- Identification of specific genes associated with MARCD presence, severity, and progression is ongoing.
Conclusions:
- Genetic factors play a crucial role in the development of WMH in MARCD.
- Identifying susceptibility genes is key for early risk stratification and personalized prevention of MARCD.